The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naäve patients with type 2 diabetes

M. Ahluwalia, M. Evans, K. Morris, C. Currie, S. Davies, A. Rees, A. Thomas

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

Peroxisome proliferator activated receptor-gamma is an important factor in adipocyte differentiation and energy metabolism and is thus a candidate gene for obesity, insulin resistance and dyslipidaemia. We therefore assessed the associations between the most common variant of the PPAR-γ, the Pro12Ala (P12A) substitution in the PPAR-γ2. gene, with BMI, blood pressure, fasting plasma glucose, HbA1c, total cholesterol, LDL and HDL cholesterol and plasma triglyceride in 183 treatment-naïve patients with type 2 diabetes (T2D). The P12A allele associated with lower fasting plasma glucose but had no influence on HbA1c, or BMI. In obese patients (BMI > 29 kg/m2), the P12A substitution associated with elevated total and non-HDL cholesterol levels.

Original languageEnglish
Pages (from-to)376-378
Number of pages3
JournalDiabetes, Obesity and Metabolism
Volume4
Issue number6
DOIs
Publication statusPublished - Nov 2002

Keywords

  • Cholesterol
  • Glucose
  • PPAR-γ
  • Type 2 diabetes

Cite this